 |
|
Intravitreal Triamcinolone Reinjection for Refractory Diabetic Macular Edema
Alireza Ramezani, Hamid Ahmadieh, Homa Tabatabaei
Korean J Ophthalmol. 2006;20(3):156-161. Published online 2006 Sep 30 DOI: https://doi.org/10.3341/kjo.2006.20.3.156
|
|
Citations to this article as recorded by
 Combination of intravitreal bevacizumab and erythropoietin versus intravitreal bevacizumab alone for refractory diabetic macular edema: a randomized double-blind clinical trial
Morteza Entezari, Zahra Kiani Flavarjani, Alireza Ramezani, Humayon Nikkhah, Saeed Karimi, Hamid Fateh Moghadam, Narsis Daftarian, Mehdi Yaseri
Graefe's Archive for Clinical and Experimental Ophthalmology.2019; 257(11): 2375. CrossRef PARS PLANA VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING FOR DIABETIC MACULAR EDEMA
KRISTEN L. HARTLEY, WILLIAM E. SMIDDY, HARRY W. FLYNN, TIMOTHY G. MURRAY
Retina.2008; 28(3): 410. CrossRef Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration
Hamid Ahmadieh, Ramin Taei, Masoud Soheilian, Mohammad Riazi-Esfahani, Reza Karkhaneh, Alireza Lashay, Mohsen Azarmina, Mohammad Hossein Dehghan, Siamak Moradian
BMC Ophthalmology.2007;[Epub] CrossRef Contributions of Inflammatory Processes to the Development of the Early Stages of Diabetic Retinopathy
Timothy S. Kern
Experimental Diabetes Research.2007; 2007: 1. CrossRef
|